Vicki Norton, Ph.D.

Patent Primogeniture: First-Filed, First-Issued And Later-Expiring Patent In A Family Immune From A Finding Of Obviousness-Type Double Patenting

FDA Finalizes New Rule For Lab-Developed Tests

FDA's New Rule Regulates Lab-Developed Tests Under FD&C Act

USPTO Proposes Significant Fee Increases Impacting Patent Prosecution Practices

White House Announces Framework For Use Of March-In Rights Under The Bayh-Dole Act To Lower Drug Prices

Coordinating IP And Regulatory Filings Can Minimize The Risk Of Inequitable Conduct Before The PTO

Silence Is Not Necessarily Golden For Negative Patent Claim Limitations

Russian Sanctions Could Impact IP Holdings In Russia And Eurasia

HHS Clarifies Broad Scope Of Immunity Protection Under The PREP Act

U.S. Food & Drug Administration Takes Steps To Allow Availability Of PPE